Section 301 Has the Tariff Power. The German Drug-Pricing Case Has the Causation Problem.
Section 301 supplies the tariff power IEEPA lacked. The German drug-pricing case is weak instead on statutory fit and the causal chain to U.S. commerce.
Written byTRAVERSE Research
Primary lensTariff authority
Evidence base7 records used
Use caseAuthority exposure review
Current analysis
Continue with Paid.
Paid opens current, deep, and evergreen analysis plus full tool output, proactive alerts, and saved-scope monitoring.